Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GeneDx Holdings (WGS) Shares Outstanding (Weighted Average) (2020 - 2025)

Historic Shares Outstanding (Weighted Average) for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to $28.8 million.

  • GeneDx Holdings' Shares Outstanding (Weighted Average) rose 628.04% to $28.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.8 million, marking a year-over-year increase of 628.04%. This contributed to the annual value of $26.9 million for FY2024, which is 1060.89% up from last year.
  • Latest data reveals that GeneDx Holdings reported Shares Outstanding (Weighted Average) of $28.8 million as of Q3 2025, which was up 628.04% from $28.6 million recorded in Q2 2025.
  • GeneDx Holdings' Shares Outstanding (Weighted Average)'s 5-year high stood at $185.7 million during Q3 2021, with a 5-year trough of $549778.0 in Q1 2021.
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $25.8 million (2023), whereas its average is $32.8 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first surged by 14974215322.58% in 2021, then crashed by 9378.59% in 2022.
  • Quarter analysis of 5 years shows GeneDx Holdings' Shares Outstanding (Weighted Average) stood at $108.1 million in 2021, then plummeted by 90.53% to $10.2 million in 2022, then soared by 137.49% to $24.3 million in 2023, then grew by 10.61% to $26.9 million in 2024, then increased by 7.09% to $28.8 million in 2025.
  • Its last three reported values are $28.8 million in Q3 2025, $28.6 million for Q2 2025, and $28.1 million during Q1 2025.